352 related articles for article (PubMed ID: 26355250)
1. Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.
Dad T; Weiner DE
Semin Nephrol; 2015 Jul; 35(4):311-22. PubMed ID: 26355250
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease and stroke.
El Husseini N; Kaskar O; Goldstein LB
Adv Chronic Kidney Dis; 2014 Nov; 21(6):500-8. PubMed ID: 25443575
[TBL] [Abstract][Full Text] [Related]
3. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
4. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
5. Cerebrorenal interaction and stroke.
Toyoda K
Contrib Nephrol; 2013; 179():1-6. PubMed ID: 23676853
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy for preventing stroke in patients with chronic kidney disease.
Kim SJ; Bang OY
Contrib Nephrol; 2013; 179():119-29. PubMed ID: 23652455
[TBL] [Abstract][Full Text] [Related]
7. Stroke in dialysis and chronic kidney disease.
Power A
Blood Purif; 2013; 36(3-4):179-83. PubMed ID: 24496188
[TBL] [Abstract][Full Text] [Related]
8. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
9. [A risk factors for stroke in the patients with chronic kidney disease].
Kes P; Basić-Kes V; Basić-Jukić N; Jurić I
Acta Med Croatica; 2011 Oct; 65 Suppl 3():67-77. PubMed ID: 23120820
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
Salim I; Al Suwaidi J; Ghadban W; Salam AM
Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
[TBL] [Abstract][Full Text] [Related]
11. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Ahmad Y; Lip GY
Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
[TBL] [Abstract][Full Text] [Related]
12. Stroke features and management in patients with chronic kidney disease.
Kamouchi M
Contrib Nephrol; 2013; 179():92-9. PubMed ID: 23652452
[TBL] [Abstract][Full Text] [Related]
13. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
[TBL] [Abstract][Full Text] [Related]
14. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
Expósito V; Seras M; Fernández-Fresnedo G
Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
[TBL] [Abstract][Full Text] [Related]
15. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
[TBL] [Abstract][Full Text] [Related]
16. Neurologic Complications of Chronic Kidney Disease.
Vellanki K; Bansal VK
Curr Neurol Neurosci Rep; 2015 Aug; 15(8):50. PubMed ID: 26081561
[TBL] [Abstract][Full Text] [Related]
17. The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease.
Schwartzenberg S; Lev EI; Sagie A; Korzets A; Kornowski R
Am J Cardiol; 2016 Feb; 117(3):477-82. PubMed ID: 26721651
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke.
Bao YS; Song LT; Zhong D; Song AX; Jia XB; Liu RC; Xie RJ; Na SP
Eur J Clin Invest; 2013 Aug; 43(8):829-35. PubMed ID: 23869408
[TBL] [Abstract][Full Text] [Related]
19. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
20. Stroke and Chronic Kidney Disease.
Kelly DM; Kelleher EM; Sood MM
Contrib Nephrol; 2021; 199():80-90. PubMed ID: 34343997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
